XML 118 R11.htm IDEA: XBRL DOCUMENT v2.4.1.9
Fair Value Measurement
3 Months Ended
Mar. 31, 2015
Fair Value Disclosures [Abstract]  
Fair value measurement
Fair value measurement
For a discussion of the Firm’s valuation methodologies for assets, liabilities and lending-related commitments measured at fair value and the fair value hierarchy, see Note 3 of JPMorgan Chase’s 2014 Annual Report.
The following table presents the asset and liabilities reported at fair value as of March 31, 2015, and December 31, 2014, by major product category and fair value hierarchy.
Assets and liabilities measured at fair value on a recurring basis
 
 
 
 
 
 
 
Fair value hierarchy
 
Derivative netting adjustments
 
March 31, 2015 (in millions)
Level 1
Level 2
 
Level 3
 
Total fair value
Federal funds sold and securities purchased under resale agreements
$

$
29,299

 
$

 
$

$
29,299

Securities borrowed

792

 

 

792

Trading assets:
 
 
 
 
 
 
 
Debt instruments:
 
 
 
 
 
 
 
Mortgage-backed securities:
 
 
 
 
 
 
 
U.S. government agencies(a)

23,873

 
888

 

24,761

Residential – nonagency

1,466

 
449

 

1,915

Commercial – nonagency

895

 
211

 

1,106

Total mortgage-backed securities

26,234

 
1,548

 

27,782

U.S. Treasury and government agencies(a)
19,935

7,055

 

 

26,990

Obligations of U.S. states and municipalities

9,178

 
1,331

 

10,509

Certificates of deposit, bankers’ acceptances and commercial paper

1,570

 

 

1,570

Non-U.S. government debt securities
23,883

32,115

 
180

 

56,178

Corporate debt securities

28,579

 
2,759

 

31,338

Loans(b)

21,246

 
10,763

 

32,009

Asset-backed securities

2,830

 
1,233

 

4,063

Total debt instruments
43,818

128,807

 
17,814

 

190,439

Equity securities
111,167

563

 
317

 

112,047

Physical commodities(c)
3,881

1,169

 

 

5,050

Other

8,830

 
1,041

 

9,871

Total debt and equity instruments(d)
158,866

139,369

 
19,172

 

317,407

Derivative receivables:
 
 
 
 
 
 
 
Interest rate
598

894,227

 
4,256

 
(862,933
)
36,148

Credit

60,642

 
2,694

 
(61,808
)
1,528

Foreign exchange
894

223,859

 
3,204

 
(202,261
)
25,696

Equity

43,644

 
2,245

 
(38,479
)
7,410

Commodity
199

38,537

 
452

 
(28,396
)
10,792

Total derivative receivables(e)
1,691

1,260,909

 
12,851

 
(1,193,877
)
81,574

Total trading assets
160,557

1,400,278

 
32,023

 
(1,193,877
)
398,981

Available-for-sale securities:
 
 
 
 
 
 
 
Mortgage-backed securities:
 
 
 
 
 
 
 
U.S. government agencies(a)

65,556

 

 

65,556

Residential – nonagency

42,580

 
23

 

42,603

Commercial – nonagency

22,507

 
99

 

22,606

Total mortgage-backed securities

130,643

 
122

 

130,765

U.S. Treasury and government agencies(a)
11,915

50

 

 

11,965

Obligations of U.S. states and municipalities

31,199

 

 

31,199

Certificates of deposit

1,023

 

 

1,023

Non-U.S. government debt securities
22,231

23,626

 

 

45,857

Corporate debt securities

17,191

 

 

17,191

Asset-backed securities:
 
 
 
 
 
 
 
Collateralized loan obligations

28,913

 
770

 

29,683

Other

11,753

 
111

 

11,864

Equity securities
2,325


 

 

2,325

Total available-for-sale securities
36,471

244,398

 
1,003

 

281,872

Loans

68

 
2,222

 

2,290

Mortgage servicing rights (“MSRs”)


 
6,641

 

6,641

Other assets:
 
 
 
 
 
 
 
Private equity investments(f)
383

254

 
2,314

 

2,951

All other
4,026

326

 
1,816

 

6,168

Total other assets
4,409

580

 
4,130

 

9,119

Total assets measured at fair value on a recurring basis
$
201,437

$
1,675,415

(g) 
$
46,019

(g) 
$
(1,193,877
)
$
728,994

Deposits
$

$
7,610

 
$
3,340

 
$

$
10,950

Federal funds purchased and securities loaned or sold under repurchase agreements

3,628

 

 

3,628

Other borrowed funds

13,343

 
1,116

 

14,459

Trading liabilities:
 
 
 
 
 
 


Debt and equity instruments(d)
65,431

18,924

 
82

 

84,437

Derivative payables:
 
 
 
 
 
 


Interest rate
659

861,758

 
3,606

 
(848,133
)
17,890

Credit

60,006

 
2,419

 
(61,205
)
1,220

Foreign exchange
880

239,402

 
2,497

 
(215,685
)
27,094

Equity

47,704

 
4,990

 
(39,504
)
13,190

Commodity
124

40,649

 
1,187

 
(27,518
)
14,442

Total derivative payables(e)
1,663

1,249,519

 
14,699

 
(1,192,045
)
73,836

Total trading liabilities
67,094

1,268,443

 
14,781

 
(1,192,045
)
158,273

Accounts payable and other liabilities


 
23

 

23

Beneficial interests issued by consolidated VIEs

258

 
1,023

 

1,281

Long-term debt

18,630

 
12,003

 

30,633

Total liabilities measured at fair value on a recurring basis
$
67,094

$
1,311,912

 
$
32,286

 
$
(1,192,045
)
$
219,247



Fair value hierarchy

Derivative netting adjustments
 

December 31, 2014 (in millions)
Level 1
Level 2

Level 3

 
Total fair value
Federal funds sold and securities purchased under resale agreements
$

$
28,585


$


$

 
$
28,585

Securities borrowed

992





 
992

Trading assets:
 
 

 

 
 
 
Debt instruments:
 
 

 

 
 
 
Mortgage-backed securities:
 
 

 

 
 
 
U.S. government agencies(a)
14

31,904


922



 
32,840

Residential – nonagency

1,381


663



 
2,044

Commercial – nonagency

927


306



 
1,233

Total mortgage-backed securities
14

34,212


1,891



 
36,117

U.S. Treasury and government agencies(a)
17,816

8,460





 
26,276

Obligations of U.S. states and municipalities

9,298


1,273



 
10,571

Certificates of deposit, bankers’ acceptances and commercial paper

1,429





 
1,429

Non-U.S. government debt securities
25,854

27,294


302



 
53,450

Corporate debt securities

28,099


2,989



 
31,088

Loans(b)

23,080


13,287



 
36,367

Asset-backed securities

3,088


1,264



 
4,352

Total debt instruments
43,684

134,960


21,006



 
199,650

Equity securities
104,890

748


431



 
106,069

Physical commodities(c)
2,739

1,741


2



 
4,482

Other

8,762


1,050



 
9,812

Total debt and equity instruments(d)
151,313

146,211


22,489



 
320,013

Derivative receivables:
 








 


Interest rate
473

945,635

(h) 
4,149


(916,532
)
(h) 
33,725

Credit

73,853


2,989


(75,004
)
 
1,838

Foreign exchange
758

212,153

(h) 
2,276


(193,934
)
(h) 
21,253

Equity

39,937

(h) 
2,552


(34,312
)
(h) 
8,177

Commodity
247

42,807


599


(29,671
)
 
13,982

Total derivative receivables(e)
1,478

1,314,385

(h) 
12,565


(1,249,453
)
(h) 
78,975

Total trading assets
152,791

1,460,596

(h) 
35,054


(1,249,453
)
(h) 
398,988

Available-for-sale securities:
 








 


Mortgage-backed securities:
 








 


U.S. government agencies(a)

65,319





 
65,319

Residential – nonagency

50,865


30



 
50,895

Commercial – nonagency

21,009


99



 
21,108

Total mortgage-backed securities

137,193


129



 
137,322

U.S. Treasury and government agencies(a)
13,591

54





 
13,645

Obligations of U.S. states and municipalities

30,068





 
30,068

Certificates of deposit

1,103





 
1,103

Non-U.S. government debt securities
24,074

28,669





 
52,743

Corporate debt securities

18,532





 
18,532

Asset-backed securities:
 








 


Collateralized loan obligations

29,402


792



 
30,194

Other

12,499


116



 
12,615

Equity securities
2,530






 
2,530

Total available-for-sale securities
40,195

257,520


1,037



 
298,752

Loans

70


2,541



 
2,611

Mortgage servicing rights



7,436



 
7,436

Other assets:
 







 
 
Private equity investments(f)
648

2,624


2,475



 
5,747

All other
4,018

230


1,914



 
6,162

Total other assets
4,666

2,854


4,389



 
11,909

Total assets measured at fair value on a recurring basis
$
197,652

$
1,750,617

(g)(h) 
$
50,457

(g) 
$
(1,249,453
)
(h) 
$
749,273

Deposits
$

$
5,948


$
2,859


$

 
$
8,807

Federal funds purchased and securities loaned or sold under repurchase agreements

2,979





 
2,979

Other borrowed funds

13,286


1,453



 
14,739

Trading liabilities:
 
 

 



 


Debt and equity instruments(d)
62,914

18,713


72



 
81,699

Derivative payables:
 
 





 
 
Interest rate
499

914,357

(h) 
3,523


(900,634
)
(h) 
17,745

Credit

73,095


2,800


(74,302
)
 
1,593

Foreign exchange
746

221,066

(h) 
2,802


(201,644
)
(h) 
22,970

Equity

41,925

(h) 
4,337


(34,522
)
(h) 
11,740

Commodity
141

44,318


1,164


(28,555
)
 
17,068

Total derivative payables(e)
1,386

1,294,761

(h) 
14,626


(1,239,657
)
(h) 
71,116

Total trading liabilities
64,300

1,313,474

(h) 
14,698


(1,239,657
)
(h) 
152,815

Accounts payable and other liabilities



26



 
26

Beneficial interests issued by consolidated VIEs

1,016


1,146



 
2,162

Long-term debt

18,349


11,877



 
30,226

Total liabilities measured at fair value on a recurring basis
$
64,300

$
1,355,052

(h) 
$
32,059


$
(1,239,657
)
(h) 
$
211,754

(a)
At March 31, 2015, and December 31, 2014, included total U.S. government-sponsored enterprise obligations of $75.2 billion and $84.1 billion, respectively, which were predominantly mortgage-related.
(b)
At March 31, 2015, and December 31, 2014, included within trading loans were $13.3 billion and $17.0 billion, respectively, of residential first-lien mortgages, and $4.4 billion and $5.8 billion, respectively, of commercial first-lien mortgages. Residential mortgage loans include conforming mortgage loans originated with the intent to sell to U.S. government agencies of $6.0 billion and $7.7 billion, respectively, and reverse mortgages of $2.9 billion and $3.4 billion, respectively.
(c)
Physical commodities inventories are generally accounted for at the lower of cost or market. “Market” is a term defined in U.S. GAAP as not exceeding fair value less costs to sell (“transaction costs”). Transaction costs for the Firm’s physical commodities inventories are either not applicable or immaterial to the value of the inventory. Therefore, market approximates fair value for the Firm’s physical commodities inventories. When fair value hedging has been applied (or when market is below cost), the carrying value of physical commodities approximates fair value, because under fair value hedge accounting, the cost basis is adjusted for changes in fair value. For a further discussion of the Firm’s hedge accounting relationships, see Note 5. To provide consistent fair value disclosure information, all physical commodities inventories have been included in each period presented.
(d)
Balances reflect the reduction of securities owned (long positions) by the amount of identical securities sold but not yet purchased (short positions).
(e)
As permitted under U.S. GAAP, the Firm has elected to net derivative receivables and derivative payables and the related cash collateral received and paid when a legally enforceable master netting agreement exists. For purposes of the tables above, the Firm does not reduce derivative receivables and derivative payables balances for this netting adjustment, either within or across the levels of the fair value hierarchy, as such netting is not relevant to a presentation based on the transparency of inputs to the valuation of an asset or liability. Therefore, the balances reported in the fair value hierarchy table are gross of any counterparty netting adjustments. However, if the Firm were to net such balances within level 3, the reduction in the level 3 derivative receivables and payables balances would be $2.3 billion and $2.5 billion at March 31, 2015, and December 31, 2014, respectively; this is exclusive of the netting benefit associated with cash collateral, which would further reduce the level 3 balances.
(f)
Private equity instruments represent investments within the Corporate line of business. The cost basis of the private equity investment portfolio totaled $4.2 billion and $6.0 billion at March 31, 2015, and December 31, 2014, respectively.
(g)
Includes investments in hedge funds, private equity funds, real estate and other funds that do not have readily determinable fair values. The Firm uses net asset value per share when measuring the fair value of these investments. At March 31, 2015, and December 31, 2014, the fair values of these investments were $1.8 billion and $1.8 billion, respectively, of which $374 million and $337 million, respectively, were classified in level 2, and $1.4 billion and $1.4 billion, respectively, in level 3.
(h)
The prior period amounts have been revised to conform with the current period presentation. This revision had no impact on the Firm's Consolidated balance sheets or its results of operations.

Transfers between levels for instruments carried at fair value on a recurring basis
For the three months ended March 31, 2015 and 2014, there were no individually significant transfers between levels 1, 2 and 3.
All transfers are assumed to occur at the beginning of the quarterly reporting period in which they occur.
Level 3 valuations
For further information on the Firm’s valuation process and a detailed discussion of the determination of fair value for individual financial instruments, see Note 3 of JPMorgan Chase’s 2014 Annual Report.
The following table presents the Firm’s primary level 3 financial instruments, the valuation techniques used to measure the fair value of those financial instruments, the significant unobservable inputs, the range of values for those inputs and, for certain instruments, the weighted averages of such inputs. While the determination to classify an instrument within level 3 is based on the significance of the unobservable inputs to the overall fair value measurement, level 3 financial instruments typically include observable components (that is, components that are actively quoted and can be validated to external sources) in addition to the unobservable components. The level 1 and/or level 2 inputs are not included in the table. In addition, the Firm manages the risk of the observable components of level 3 financial instruments using securities and derivative positions that are classified within levels 1 or 2 of the fair value hierarchy.
The range of values presented in the table is representative of the highest and lowest level input used to value the significant groups of instruments within a product/instrument classification. Where provided, the weighted averages of the input values presented in the table are calculated based on the fair value of the instruments that the input is being used to value.
In the Firm’s view, the input range and the weighted average value do not reflect the degree of input uncertainty or an assessment of the reasonableness of the Firm’s estimates and assumptions. Rather, they reflect the characteristics of the various instruments held by the Firm and the relative distribution of instruments within the range characteristics. For example, two option contracts may have similar levels of market risk exposure and valuation uncertainty, but may have significantly different implied volatility levels because the option contracts have different underlyings, tenors, or strike prices. The input range and weighted average values will therefore vary from period-to period and parameter to parameter based on the characteristics of the instruments held by the Firm at each balance sheet date.
For the Firm’s derivatives and structured notes positions classified within level 3, the equity and interest rate correlation inputs used in estimating fair value were concentrated at the upper end of the range presented, while the credit correlation inputs were distributed across the range presented and the foreign exchange correlation inputs were concentrated at the top end of the range presented. In addition, the interest rate volatility inputs used in estimating fair value were concentrated at the upper end of the range presented and the foreign exchange correlation inputs were concentrated at the top end of the range presented. The equity volatilities are concentrated at the lower half end of the range. The forward commodity prices used in estimating the fair value of commodity derivatives were concentrated within the lower end of the range presented.
Level 3 inputs(a)
 
March 31, 2015 (in millions, except for ratios and basis points)
 
 
 
 
 
Product/Instrument
Fair value
 
Principal valuation technique
Unobservable inputs
Range of input values
Weighted average
Residential mortgage-backed securities and loans
$
6,816

 
Discounted cash flows
Yield
1
 %
24%
5
%
 
 
 
Prepayment speed
0
 %
20%
7
%
 
 
 
 
Conditional default rate
0
 %
100%
10
%
 
 
 
 
Loss severity
0
 %
100%
27
%
Commercial mortgage-backed securities and loans(b)
4,634

 
Discounted cash flows
Yield
1
 %
34%
4
%
 
 
 
Conditional default rate
0
 %
100%
7
%
 
 
 
 
Loss severity
0
 %
40%
28
%
Corporate debt securities, obligations of U.S. states and municipalities, and other(c)
6,434

 
Discounted cash flows
Credit spread
60 bps

350 bps
158 bps

 
 
 
Yield
2
 %
16%
5
%
5,268

 
Market comparables
Price
$

$139
$
105

Net interest rate derivatives
650

 
Option pricing
Interest rate correlation
(75
)%
93%
 
 
 
 
 
Interest rate spread volatility
0
 %
60%
 
Net credit derivatives(b)(c)
275

 
Discounted cash flows
Credit correlation
40
 %
90%
 
Net foreign exchange derivatives
707

 
Option pricing
Foreign exchange correlation
0
 %
60%
 
Net equity derivatives
(2,745
)
 
Option pricing
Equity volatility
15
 %
60%
 
Net commodity derivatives
(735
)
 
Discounted cash flows
Forward commodity price
$
50

$90 per barrel
Collateralized loan obligations
770

 
Discounted cash flows
Credit spread
275 bps

445 bps
296 bps

 
 
 
 
Prepayment speed
20%
20
%
 
 
 
 
Conditional default rate
2%
2
%
 
 
 
 
Loss severity
40%
40
%
 
291

 
Market comparables
Price
$

$140
$
83

Mortgage servicing rights (“MSRs”)
6,641

 
Discounted cash flows
Refer to Note 16
 
Private equity direct investments
1,897

 
Market comparables
EBITDA multiple
6.9x

11.8x
8.5x

 
 
 
Liquidity adjustment
0
 %
15%
10
%
Private equity fund investments
417

 
Net asset value
Net asset value(e)
 
 
Long-term debt, other borrowed funds, and deposits(d)
15,195

 
Option pricing
Interest rate correlation
(75
)%
93%
 
 
 
 
Interest rate spread volatility
0
 %
60%
 
 
 
 
Foreign exchange correlation
0
 %
60%
 
 
 
 
Equity correlation
(50
)%
85%
 
 
1,264

 
Discounted cash flows
Credit correlation
40
 %
90%
 
(a)
The categories presented in the table have been aggregated based upon the product type, which may differ from their classification on the Consolidated balance sheets.
(b)
The unobservable inputs and associated input ranges for approximately $465 million of credit derivative receivables and $408 million of credit derivative payables with underlying commercial mortgage risk have been included in the inputs and ranges provided for commercial mortgage-backed securities (“MBS”) and loans.
(c)
The unobservable inputs and associated input ranges for approximately $746 million of credit derivative receivables and $654 million of credit derivative payables with underlying asset-backed securities (“ABS”) risk have been included in the inputs and ranges provided for corporate debt securities, obligations of U.S. states and municipalities and other.
(d)
Long-term debt, other borrowed funds and deposits include structured notes issued by the Firm that are predominantly financial instruments containing embedded derivatives. The estimation of the fair value of structured notes is predominantly based on the derivative features embedded within the instruments. The significant unobservable inputs are broadly consistent with those presented for derivative receivables.
(e)
The range has not been disclosed due to the wide range of possible values given the diverse nature of the underlying investments.
Changes in and ranges of unobservable inputs
For a discussion of the impact on fair value of changes in unobservable inputs and the relationships between unobservable inputs as well as a description of attributes of the underlying instruments and external market factors that affect the range of inputs used in the valuation of the Firm’s positions see Note 3 of JPMorgan Chase’s 2014 Annual Report.
Changes in level 3 recurring fair value measurements
The following tables include a rollforward of the Consolidated balance sheets amounts (including changes in fair value) for financial instruments classified by the Firm within level 3 of the fair value hierarchy for the three months ended March 31, 2015 and 2014. When a determination is made to classify a financial instrument within level 3, the determination is based on the significance of the unobservable parameters to the overall fair value measurement. However, level 3 financial instruments typically include, in addition to the unobservable or level 3 components, observable components (that is, components that are actively quoted and can be validated to external sources); accordingly, the gains and losses in the table below include changes in fair value due in part to observable factors that are part of the valuation methodology. Also, the Firm risk-manages the observable components of level 3 financial instruments using securities and derivative positions that are classified within level 1 or 2 of the fair value hierarchy; as these level 1 and level 2 risk management instruments are not included below, the gains or losses in the following tables do not reflect the effect of the Firm’s risk management activities related to such level 3 instruments.
 
Fair value measurements using significant unobservable inputs
 
 
Three months ended
March 31, 2015
(in millions)
Fair value at January 1, 2015
Total realized/unrealized gains/(losses)
 
 
 
 
Transfers into and/or out of level 3(h)
Fair value at
March 31, 2015
Change in unrealized gains/(losses) related
to financial instruments held at March 31, 2015
Purchases(g)
Sales
 
Settlements
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
Trading assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
Debt instruments:
 
 
 
 
 
 
 
 
 
 
 
 
 
Mortgage-backed securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. government agencies
$
922

$
(53
)
 
$
74

$
(17
)
 
$
(40
)
$
2

 
$
888

 
$
(52
)
 
Residential – nonagency
663

(10
)
 
152

(347
)
 
(6
)
(3
)
 
449

 
(34
)
 
Commercial – nonagency
306

(11
)
 
82

(151
)
 
(8
)
(7
)
 
211

 
(16
)
 
Total mortgage-backed securities
1,891

(74
)
 
308

(515
)
 
(54
)
(8
)
 
1,548

 
(102
)
 
Obligations of U.S. states and municipalities
1,273

10

 
144

(71
)
 
(25
)

 
1,331

 
8

 
Non-U.S. government debt securities
302

1

 
101

(92
)
 
(31
)
(101
)
 
180

 
1

 
Corporate debt securities
2,989

(55
)
 
533

(496
)
 
(92
)
(120
)
 
2,759

 
(26
)
 
Loans
13,287

(285
)
 
736

(1,997
)
 
(469
)
(509
)
 
10,763

 
(275
)
 
Asset-backed securities
1,264

(37
)
 
559

(521
)
 
32

(64
)
 
1,233

 
(44
)
 
Total debt instruments
21,006

(440
)
 
2,381

(3,692
)
 
(639
)
(802
)
 
17,814

 
(438
)
 
Equity securities
431

38

 
29

(110
)
 
(3
)
(68
)
 
317

 
31

 
Other
1,052

8

 
661

(584
)
 
(79
)
(17
)
 
1,041

 
15

 
Total trading assets – debt and equity instruments
22,489

(394
)
(c) 
3,071

(4,386
)
 
(721
)
(887
)
 
19,172

 
(392
)
(c) 
Net derivative receivables:(a)
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate
626

142

 
309

(74
)
 
(255
)
(98
)
 
650

 
308

 
Credit
189

77

 
9

(3
)
 
19

(16
)
 
275

 
75

 
Foreign exchange
(526
)
827

 
5

(3
)
 
201

203

 
707

 
779

 
Equity
(1,785
)
(476
)
 
208

(289
)
 
(355
)
(48
)
 
(2,745
)
 
(484
)
 
Commodity
(565
)
(40
)
 


 
(98
)
(32
)
 
(735
)
 
(49
)
 
Total net derivative receivables
(2,061
)
530

(c) 
531

(369
)
 
(488
)
9

 
(1,848
)
 
629

(c) 
Available-for-sale securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
Asset-backed securities
908

(9
)
 
49

(43
)
 
(24
)

 
881

 
(4
)
 
Other
129


 


 
(7
)

 
122

 

 
Total available-for-sale securities
1,037

(9
)
(d) 
49

(43
)
 
(31
)

 
1,003

 
(4
)
(d) 
Loans
2,541

(205
)
(c) 
120

(83
)
 
(151
)

 
2,222

 
(205
)
(c) 
Mortgage servicing rights
7,436

(579
)
(e) 
156

(157
)
 
(215
)

 
6,641

 
(579
)
(e) 
Other assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
Private equity investments
2,475

36

(c) 


 
(71
)
(126
)
 
2,314

 
21

(c) 
All other
1,914

19

(f) 
95

(88
)
 
(124
)

 
1,816

 
2

(f) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fair value measurements using significant unobservable inputs
 
 
Three months ended
March 31, 2015
(in millions)
Fair value at January 1, 2015
Total realized/unrealized (gains)/losses
 
 
 
 
Transfers into and/or out of level 3(h)
Fair value at
March 31, 2015
Change in unrealized (gains)/losses related
to financial instruments held at March 31, 2015
Purchases
Sales
Issuances
Settlements
Liabilities:(b)
 
 
 
 
 
 
 
 
 
 
 
 
 
Deposits
$
2,859

$
92

(c) 
$

$

$
775

$
(115
)
$
(271
)
 
$
3,340

 
$
88

(c) 
Other borrowed funds
1,453

(119
)
(c) 


1,048

(981
)
(285
)
 
1,116

 
(110
)
(c) 
Trading liabilities – debt and equity instruments
72

3

(c) 
(108
)
126


(9
)
(2
)
 
82

 
2

(c) 
Accounts payable and other liabilities
26


(c) 



(3
)

 
23

 

(c) 
Beneficial interests issued by consolidated VIEs
1,146

(53
)
(c) 


2

(72
)

 
1,023

 
(47
)
(c) 
Long-term debt
11,877

(105
)
(c) 

(12
)
2,837

(2,371
)
(223
)
 
12,003

 
(96
)
(c) 


 
Fair value measurements using significant unobservable inputs
 
 
Three months ended
March 31, 2014
(in millions)
Fair value at January 1, 2014
Total realized/unrealized gains/(losses)





Transfers into and/or out of level 3(h)
Fair value at
March 31, 2014
Change in unrealized gains/(losses) related
to financial instruments held at March 31, 2014
Purchases(g)

Sales

Settlements
Assets:























Trading assets:























Debt instruments:























Mortgage-backed securities:























U.S. government agencies
$
1,005

$
3


$
331


$
(162
)


$
(27
)
$


$
1,150


$
5


Residential – nonagency
726

24


192


(200
)


(12
)
(15
)

715


14


Commercial – nonagency
432

20


321


(294
)


(14
)


465


10


Total mortgage-backed securities
2,163

47


844


(656
)


(53
)
(15
)

2,330


29


Obligations of U.S. states and municipalities
1,382

22




(185
)





1,219


9


Non-U.S. government debt securities
143

16


410


(516
)


(1
)


52


22


Corporate debt securities
5,920

238


1,197


(1,352
)


(841
)
(289
)

4,873


213


Loans
13,455

319


2,158


(1,794
)


(1,546
)
(71
)

12,521


295


Asset-backed securities
1,272

24


550


(556
)


(20
)
(114
)

1,156


19


Total debt instruments
24,335

666


5,159


(5,059
)


(2,461
)
(489
)

22,151


587


Equity securities
885

81


36


(19
)


(9
)
(89
)

885


70


Physical commodities
4








(1
)


3




Other
2,000

(97
)

54


(51
)


(28
)
(594
)

1,284


(19
)

Total trading assets – debt and equity instruments
27,224

650

(c) 
5,249


(5,129
)


(2,499
)
(1,172
)

24,323


638

(c) 
Net derivative receivables:(a)
 
 

 

 


 
 

 

 

Interest rate
2,379

24


48


(43
)


(338
)
20


2,090


(342
)

Credit
95

(115
)

58





206



244


(97
)

Foreign exchange
(1,200
)
(199
)

61


(16
)


49

23


(1,282
)

(349
)

Equity
(1,063
)
71


801


(1,033
)

125

39


(1,060
)

582


Commodity
115

(154
)

1





(42
)
22


(58
)

(60
)

Total net derivative receivables
326

(373
)
(c) 
969


(1,092
)



104


(66
)

(266
)
(c) 
Available-for-sale securities:
 
 

 

 


 
 

 

 

Asset-backed securities
1,088

(2
)



(2
)


(20
)
63


1,127


(2
)

Other
1,234

(3
)






(41
)


1,190


(3
)

Total available-for-sale securities
2,322

(5
)
(d) 


(2
)


(61
)
63


2,317


(5
)
(d) 
Loans
1,931

32

(c) 
684


(142
)


(234
)


2,271


28

(c) 
Mortgage servicing rights
9,614

(822
)
(e) 
195


(188
)


(247
)


8,552


(822
)
(e) 
Other assets:
 
 

 

 


 
 

 

 

Private equity investments
6,474

96

(c) 
87


(1,018
)


(304
)


5,335


(3
)
(c) 
All other
2,589

(34
)
(f) 
73


(37
)


(155
)


2,436


(44
)
(f) 























Fair value measurements using significant unobservable inputs


Three months ended
March 31, 2014
(in millions)
Fair value at January 1, 2014
Total realized/unrealized (gains)/losses





Transfers into and/or out of level 3(h)
Fair value at March 31, 2014
Change in unrealized (gains)/
losses related
to financial instruments held at March 31, 2014
Purchases

Sales
Issuances
Settlements
Liabilities:(b)





















Deposits
$
2,255

$
37

(c) 
$


$

$
290

$
(42
)
$
(154
)

$
2,386


$
28

(c) 
Other borrowed funds
2,074

39

(c) 



1,333

(2,107
)
196


1,535


113

(c) 
Trading liabilities – debt and equity instruments
113



(216
)

208


(4
)


101




Accounts payable and other liabilities














Beneficial interests issued by consolidated VIEs
1,240

47

(c) 



78

(205
)


1,160


50

(c) 
Long-term debt
10,008

102

(c) 



1,832

(1,010
)
271


11,203


129

(c) 

(a)
All level 3 derivatives are presented on a net basis, irrespective of the underlying counterparty.
(b)
Level 3 liabilities as a percentage of total Firm liabilities accounted for at fair value (including liabilities measured at fair value on a nonrecurring basis) was 15% at March 31, 2015 and December 31, 2014.
(c)
Predominantly reported in principal transactions revenue, except for changes in fair value for Consumer & Community Banking mortgage loans, lending-related commitments originated with the intent to sell, and mortgage loan purchase commitments, which are reported in mortgage fees and related income.
(d)
Realized gains/(losses) on available-for-sale (“AFS”) securities, as well as other-than-temporary impairment losses that are recorded in earnings, are reported in securities gains. Unrealized gains/(losses) are reported in OCI. Realized gains/(losses) and foreign exchange remeasurement adjustments recorded in income on AFS securities were $(7) million and $(1) million for the three months ended March 31, 2015 and 2014, respectively. Unrealized gains/(losses) recorded on AFS securities in OCI were $(2) million and $(4) million for the three months ended March 31, 2015 and 2014, respectively.
(e)
Changes in fair value for CCB mortgage servicing rights are reported in mortgage fees and related income.
(f)
Predominantly reported in other income.
(g)
Loan originations are included in purchases.
(h)
All transfers into and/or out of level 3 are assumed to occur at the beginning of the quarterly reporting period in which they occur.

Level 3 analysis
Consolidated balance sheets changes
Level 3 assets (including assets measured at fair value on a nonrecurring basis) were 1.9% of total Firm assets at March 31, 2015. The following describes significant changes to level 3 assets since December 31, 2014, for those items measured at fair value on a recurring basis. For further information on changes impacting items measured at fair value on a nonrecurring basis, see Assets and liabilities measured at fair value on a nonrecurring basis on page 87.
Three months ended March 31, 2015
Level 3 assets were $46.0 billion at March 31, 2015, reflecting a decrease of $4.4 billion from December 31, 2014, largely due to the following:
$3.3 billion decrease in trading assets, debt and equity securities predominantly driven by a decrease in trading loans due to sales and a number of transfers from Level 3 to Level 2 as a result of an increase in observability of certain valuation inputs.
Gains and losses
The following describes significant components of total realized/unrealized gains/(losses) for instruments measured at fair value on a recurring basis for the periods indicated. For further information on these instruments, see Changes in level 3 recurring fair value measurements rollforward tables on pages 84–85.
Three months ended March 31, 2015
$602 million of net losses and $182 million of net gains on assets and liabilities, respectively, measured at fair value on a recurring basis, none of which were individually significant.
Three months ended March 31, 2014
$456 million and $225 million of net losses on assets and liabilities, respectively, measured at fair value on a recurring basis, none of which were individually significant.
Credit & funding adjustments
The following table provides the credit and funding adjustments, excluding the effect of any associated hedging activities, reflected within the Consolidated balance sheets as of the dates indicated.
(in millions)
Mar 31, 2015
 
Dec 31, 2014
Derivative receivables balance(a)
$
81,574

 
$
78,975

Derivative payables balance(a)
73,836

 
71,116

Derivatives CVA(b)
(2,493
)
 
(2,674
)
Derivatives DVA and FVA(b)(c)
(521
)
 
(380
)
Structured notes balance(a)(d)
56,042

 
53,772

Structured notes DVA and FVA(b)(e)
1,300

 
1,152

(a)
Balances are presented net of applicable credit valuation adjustments (“CVA”) and debit valuation adjustments (“DVA”)/funding valuation adjustments (“FVA”).
(b)
Positive CVA and DVA/FVA represent amounts that increased receivable balances or decreased payable balances; negative CVA and DVA/FVA represent amounts that decreased receivable balances or increased payable balances.
(c)
At March 31, 2015, and December 31, 2014, included derivatives DVA of $727 million and $714 million, respectively.
(d)
Structured notes are predominantly financial instruments containing embedded derivatives that are measured at fair value based on the Firm’s election under the fair value option. At March 31, 2015, and December 31, 2014, included $943 million and $943 million, respectively, of financial instruments with no embedded derivative for which the fair value option has also been elected. For further information on these elections, see Note 4.
(e)
At March 31, 2015, and December 31, 2014 included structured notes DVA of $1.5 billion and $1.4 billion, respectively.
The following table provides the impact of credit and funding adjustments on Principal transactions revenue in the respective periods, excluding the effect of any associated hedging activities.
 
Three months ended
March 31,
(in millions)
2015
 
2014
Credit adjustments:
 
 
 
Derivatives CVA
$
181

 
$
(19
)
Derivatives DVA and FVA(a)
(141
)
 
(125
)
Structured notes DVA and FVA(b)
148

 
17

(a)
Included derivatives DVA of $13 million and $(94) million for the three months ended March 31, 2015 and 2014, respectively.
(b)
Included structured notes DVA of $108 million and $(115) million for the three months ended March 31, 2015 and 2014, respectively.
Assets and liabilities measured at fair value on a nonrecurring basis
At March 31, 2015 and 2014, assets measured at fair value on a nonrecurring basis were $3.5 billion and $3.8 billion, respectively, which predominantly consisted of loans that had fair value adjustments for the three months ended March 31, 2015 and 2014. At March 31, 2015, $1.3 billion and $2.2 billion of these assets were classified in levels 2 and 3 of the fair value hierarchy, respectively. At March 31, 2014, $333 million and $3.5 billion of these assets were classified in levels 2 and 3 of the fair value hierarchy, respectively. Liabilities measured at fair value on a nonrecurring basis were not significant at March 31, 2015 and 2014. For the three months ended March 31, 2015 and 2014, there were no significant transfers between levels 1, 2, and 3.
Of the $2.2 billion of level 3 assets measured at fair value on a nonrecurring basis as of March 31, 2015:
$1.3 billion related to consumer credit card loans that were reclassified to held-for-sale during the fourth quarter of 2014 subject to a lower of cost or fair value adjustment. These loans were classified as level 3, as they are valued based on the Firm’s internal valuation methodology;
$495 million related to trade finance loans that were reclassified to held-for-sale during the fourth quarter of 2013 and subject to a lower of cost or fair value adjustment. These loans were classified as level 3 as they are valued based on the indicative pricing received from external investors, with a spread and weighted average of 58 bps.
$186 million related to residential real estate loans measured at the net realizable value of the underlying collateral (i.e., collateral-dependent loans and other loans charged off in accordance with regulatory guidance). These amounts are classified as level 3 as they are valued using a broker’s price opinion and discounted based upon the Firm’s experience with actual liquidation values. These discounts to the broker price opinions ranged from 8% to 59%, with a weighted average of 22%.
The total change in the recorded value of assets and liabilities for which a fair value adjustment has been included in the Consolidated Statements of Income for the three months ended March 31, 2015 and 2014, related to financial instruments held at those dates, was a reduction of $88 million and $226 million, respectively.
For information about the measurement of impaired collateral-dependent loans, and other loans where the carrying value is based on the fair value of the underlying collateral (e.g., residential mortgage loans charged off in accordance with regulatory guidance), see Note 14 of JPMorgan Chase’s 2014 Annual Report.
Additional disclosures about the fair value of financial instruments that are not carried on the Consolidated balance sheets at fair value
The following table presents the carrying values and estimated fair values at March 31, 2015, and December 31, 2014, of financial assets and liabilities, excluding financial instruments which are carried at fair value on a recurring basis, and information is provided on their classification within the fair value hierarchy. For additional information regarding the financial instruments within the scope of this disclosure, and the methods and significant assumptions used to estimate their fair value, see Note 3 of JPMorgan Chase’s 2014 Annual Report.
 
March 31, 2015
 
December 31, 2014
 
 
Estimated fair value hierarchy
 
 
 
Estimated fair value hierarchy
 
(in billions)
Carrying
value
Level 1
Level 2
Level 3
Total estimated
fair value
 
Carrying
value
Level 1
Level 2
Level 3
Total estimated
fair value
Financial assets
 
 
 
 
 
 
 
 
 
 
 
Cash and due from banks
$
22.8

$
22.8

$

$

$
22.8

 
$
27.8

$
27.8

$

$

$
27.8

Deposits with banks
506.4

502.8

3.6


506.4

 
484.5

480.4

4.1


484.5

Accrued interest and accounts receivable
70.0


70.0

0.1

70.1

 
70.1


70.0

0.1

70.1

Federal funds sold and securities purchased under resale agreements
190.0


190.0


190.0

 
187.2


187.2


187.2

Securities borrowed
107.6


107.6


107.6

 
109.4


109.4


109.4

Securities, held-to-maturity(a)
49.3


51.4


51.4

 
49.3


51.2


51.2

Loans, net of allowance for loan losses(b)
747.8


18.3

734.4

752.7

 
740.5


21.8

723.1

744.9

Other
65.8


56.5

13.3

69.8

 
64.7


55.7

13.3

69.0

Financial liabilities
 
 
 
 
 
 
 
 
 
 
 
Deposits
$
1,356.9

$

$
1,356.0

$
1.2

$
1,357.2

 
$
1,354.6

$

$
1,353.6

$
1.2

$
1,354.8

Federal funds purchased and securities loaned or sold under repurchase agreements
193.0


193.0


193.0

 
189.1


189.1


189.1

Commercial paper
55.7


55.7


55.7

 
66.3


66.3


66.3

Other borrowed funds
14.6


14.6


14.6

 
15.5



15.5


15.5

Accounts payable and other liabilities
174.5


172.0

2.4

174.4

 
176.7


173.7

2.9

176.6

Beneficial interests issued by consolidated VIEs
49.8


47.9

2.0

49.9

 
50.2


48.2

2.0

50.2

Long-term debt and junior subordinated deferrable interest debentures(c)
250.0


255.9

3.8

259.7

 
246.6


251.6

3.8

255.4

(a)
Carrying value includes unamortized discount or premium.
(b)
Fair value is typically estimated using a discounted cash flow model that incorporates the characteristics of the underlying loans (including principal, contractual interest rate and contractual fees) and other key inputs, including expected lifetime credit losses, interest rates, prepayment rates, and primary origination or secondary market spreads. For certain loans, the fair value is measured based on the value of the underlying collateral. The difference between the estimated fair value and carrying value of a financial asset or liability is the result of the different methodologies used to determine fair value as compared with carrying value. For example, credit losses are estimated for a financial asset’s remaining life in a fair value calculation but are estimated for a loss emergence period in the allowance for loan loss calculation; future loan income (interest and fees) is incorporated in a fair value calculation but is generally not considered in the allowance for loan losses. For a further discussion of the Firm’s methodologies for estimating the fair value of loans and lending-related commitments, see Valuation hierarchy on pages 181–184 of JPMorgan Chase’s 2014 Annual Report.
(c)
Carrying value includes unamortized original issue discount and other valuation adjustments.

The majority of the Firm’s lending-related commitments are not carried at fair value on a recurring basis on the Consolidated Balance Sheets, nor are they actively traded. The carrying value and estimated fair value of the Firm’s wholesale lending-related commitments were as follows for the periods indicated.
 
March 31, 2015
 
December 31, 2014
 
 
Estimated fair value hierarchy
 
 
 
Estimated fair value hierarchy
 
(in billions)
Carrying value(a)
Level 1
Level 2
Level 3
Total estimated fair value
 
Carrying value(a)
Level 1
Level 2
Level 3
Total estimated fair value
Wholesale lending-related commitments
$
0.6

$

$

$
1.3

$
1.3

 
$
0.6

$

$

$
1.6

$
1.6

(a)
Represents the allowance for wholesale lending-related commitments. Excludes the current carrying values of the guarantee liability and the offsetting asset, each of which are recognized at fair value at the inception of guarantees.
The Firm does not estimate the fair value of consumer lending-related commitments. In many cases, the Firm can reduce or cancel these commitments by providing the borrower notice or, in some cases as permitted by law, without notice. For a further discussion of the valuation of lending-related commitments, see page 182 of JPMorgan Chase’s 2014 Annual Report.